ZA94155B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA94155B ZA94155B ZA94155A ZA94155A ZA94155B ZA 94155 B ZA94155 B ZA 94155B ZA 94155 A ZA94155 A ZA 94155A ZA 94155 A ZA94155 A ZA 94155A ZA 94155 B ZA94155 B ZA 94155B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA928567 | 1992-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA94155B true ZA94155B (en) | 1995-07-11 |
Family
ID=25582297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA94155A ZA94155B (en) | 1992-11-06 | 1994-01-11 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA94155B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996035452A1 (en) * | 1995-05-10 | 1996-11-14 | Adcock Ingram Limited | Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders |
WO1997003649A1 (en) * | 1995-07-24 | 1997-02-06 | Co-Ordinated Drug Development Ltd. | Improvements in and relating to powders for use in dry powder inhalers |
WO2005013963A1 (en) | 2003-08-06 | 2005-02-17 | Galephar M/F | Advantageous combinations for inhalation of nacystelyn and bronchodilators |
US7011818B2 (en) | 1995-01-31 | 2006-03-14 | Vectura Limited | Carrier particles for use in dry powder inhalers |
WO2006030221A1 (en) * | 2004-09-15 | 2006-03-23 | Cipla Limited | Pharmaceutical composition comprising a betaminetic agent and a mucolytic agent |
-
1994
- 1994-01-11 ZA ZA94155A patent/ZA94155B/en unknown
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7011818B2 (en) | 1995-01-31 | 2006-03-14 | Vectura Limited | Carrier particles for use in dry powder inhalers |
US7718163B2 (en) | 1995-01-31 | 2010-05-18 | Vectura Limited (01696917) | Carrier particles for use in dry powder inhalers |
US8920781B2 (en) | 1995-01-31 | 2014-12-30 | Vectura Limited | Carrier particles for use in dry powder inhalers |
WO1996035452A1 (en) * | 1995-05-10 | 1996-11-14 | Adcock Ingram Limited | Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders |
WO1997003649A1 (en) * | 1995-07-24 | 1997-02-06 | Co-Ordinated Drug Development Ltd. | Improvements in and relating to powders for use in dry powder inhalers |
US6475523B1 (en) | 1995-07-24 | 2002-11-05 | Vectura Limited | Powders comprising anti-adherant materials for use in dry powder inhalers |
EP1213012A3 (en) * | 1995-07-24 | 2002-12-04 | Vectura Limited | Improvements in and relating to powders for use in dry powder inhalers |
WO2005013963A1 (en) | 2003-08-06 | 2005-02-17 | Galephar M/F | Advantageous combinations for inhalation of nacystelyn and bronchodilators |
EP1658063B1 (en) * | 2003-08-06 | 2014-03-12 | Galephar M/F | Advantageous combinations for inhalation of nacystelyn and bronchodilators |
WO2006030221A1 (en) * | 2004-09-15 | 2006-03-23 | Cipla Limited | Pharmaceutical composition comprising a betaminetic agent and a mucolytic agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA938825B (en) | Pharmaceutical compositions | |
GB9308014D0 (en) | Pharmaceutical compositions | |
GB9319500D0 (en) | Pharmaceutical composition | |
HUT66864A (en) | Pharmaceutical compositions | |
GB2272375B (en) | Pharmaceutical composition | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
GB9209874D0 (en) | Pharmaceutical compositions | |
CA2100836A1 (en) | Pharmaceutical Composition | |
ZA937592B (en) | Pharmaceutical composition | |
ZA94155B (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
GB9226377D0 (en) | Pharmaceutical compositions | |
ZA935931B (en) | Pharmaceutical composition | |
ZA924061B (en) | Pharmaceutical composition | |
GB9211276D0 (en) | Pharmaceutical compositions | |
ZA931984B (en) | Pharmaceutical composition | |
GB9225159D0 (en) | Pharmaceutical composition | |
GB9211903D0 (en) | Pharmaceutical composition | |
GB9209520D0 (en) | Pharmaceutical composition | |
GB9204472D0 (en) | Pharmaceutical composition | |
GB9210335D0 (en) | Pharmaceutical composition | |
GB9216596D0 (en) | Pharmaceutical composition | |
GB9225170D0 (en) | Pharmaceutical composition | |
GB9216600D0 (en) | Pharmaceutical composition | |
GB9206046D0 (en) | Pharmaceutical composition |